> At a certain point, virtual molecules must give way to the real thing. > Using the newly identified pharmacophore as a new map, a drug company > or research lab will synthesize and test molecules in a lab environment > to analyze non-virtual reactions. However, in this project, all results > from the virtual screening will remain with the University of Oxford > and the NFCR. That is, the rights to the research results remain with > non-profit organizations that are dedicated to cancer research.
> This will mark the beginning of many tests that must take place in > the lab to test a drug and move towards the commercial production > required to help real cancer patients. Identifying molecule interactions > is a good start on the road to a cure, but a good biochemical reaction > isn't all that is needed. The molecules then need to be tested to ensure > that they work with the human body. And they need to be affordable to > synthesize so that a commercial drug can be developed from them.